Nasdaq

BioRestorative Therapies, Inc. Receives FDA IND Clearance for BRTX-100 to Treat Chronic Cervical Discogenic Pain

BioRestorative Therapies, Inc. announced that the FDA has cleared its Investigational New Drug application for BRTX-100, marking it as the first stem cell product candidate approved for evaluation in ...
Nasdaq

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain

MELVILLE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...
Yahoo

FDA clears SurGenTec’s facet fixation system for degenerative disc disease treatment

SurGenTec has secured US Food and Drug Administration (FDA) clearance for ION-L, a lumbar facet fixation system for treating degenerative disc disease (DDD) patients who have not benefited from ...
The Providence Journal

Experiencing low back pain? Clinical trial at Brown Health could help.

A clinical trial at Brown University Health to treat chronic low back pain with a one-time, non-surgical injection treatment is seeking to enroll patients in Rhode Island. The trial is testing whether ...